Neogenomics Inc (NASDAQ: NEO) is -23.36% lower on its value in year-to-date trading and has touched a low of $12.77 and a high of $19.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NEO stock was last observed hovering at around $14.77 in the last trading session, with the day’s loss setting it -2.14%.
Currently trading at $12.63, the stock is -25.08% and -23.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.53 million and changing -14.49% at the moment leaves the stock -16.77% off its SMA200. NEO registered -20.91% loss for a year compared to 6-month gain of -14.60%. The firm has a 50-day simple moving average (SMA 50) of $16.5116 and a 200-day simple moving average (SMA200) of $15.1874.
The stock witnessed a -31.47% loss in the last 1 month and extending the period to 3 months gives it a -6.72%, and is -25.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.94% over the week and 5.66% over the month.
Neogenomics Inc (NEO) has around 2100 employees, a market worth around $1.62B and $644.12M in sales. Fwd P/E is 62.42. Profit margin for the company is -12.07%. Distance from 52-week low is -1.10% and -33.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.93%).
with sales reaching $173.23M over the same period.The EPS is expected to grow by 181.85% this year, but quarterly earnings will post 11.89% year-over-year. Quarterly sales are estimated to grow 11.37% in year-over-year returns.
Neogenomics Inc (NEO) Top Institutional Holders
375.0 institutions hold shares in Neogenomics Inc (NEO), with institutional investors hold 100.71% of the company’s shares. The shares outstanding are 128.06M, and float is at 126.84M with Short Float at 3.04%. Institutions hold 99.50% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 19.67 million shares valued at $272.82 million. The investor’s holdings represent 15.5612% of the NEO Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 14.12 million shares valued at $195.87 million to account for 11.1716 of the shares outstanding. The other top investors are BROWN ADVISORY INC which holds 8.77 million shares representing 6.9391% and valued at over $121.66 million, while T. ROWE PRICE INVESTMENT MANAGEMENT, INC. holds 5.3244 of the shares totaling 6.73 million with a market value of $93.35 million.
Neogenomics Inc (NEO) Insider Activity
The most recent transaction is an insider sale by Olivo Alicia C, the company’s General Counsel. SEC filings show that Olivo Alicia C sold 5,175 shares of the company’s common stock on Nov 15 ’24 at a price of $15.36 per share for a total of $79475.0. Following the sale, the insider now owns 37129.0 shares.
Still, SEC filings show that on Aug 15 ’24, Olivo Alicia C (General Counsel) disposed off 1,040 shares at an average price of $16.05 for $16695.0. The insider now directly holds 43,813 shares of Neogenomics Inc (NEO).